Author:
Giroud Christian,Horisberger Beat,Eap Chin,Augsburger Marc,Ménétrey Annick,Baumann Pierre,Mangin Patrice
Subject
Pathology and Forensic Medicine,Law
Reference32 articles.
1. Moclobemide: evolution, pharmacodynamic, and pharmacokinetic properties;Bonnet;CNS Drug Rev.,2002
2. Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A;Prada;J. Pharmacol. Exp. Ther.,1989
3. M. Bergstrom, G. Westerberg, G. Nemeth, M. Traut, G. Gross, G. Greger, H. Muller-Peltzer, A. Safer, S.A. Eckernas, A. Grahner, B. Langstrom, MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: in vivo studies with positron emission tomography, Eur. J. Clin. Pharmacol. 52 (1997) 121–128.
4. Aurorix™ (moclobemide) Product Monograph, Hoffman-La Roche AG, Basel, 1990.
5. Determination of the new monoamine oxidase inhibitor moclobemide and three of its metabolites in biological fluids by high-performance liquid chromatography;Geschke;J. Chromatogr.,1987
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献